NEW YORK (TheStreet) -- There are hundreds of hospital across America and around the world that need specific kinds of products and services. Perhaps the most important ones they're buying involve minimizing procedural errors and maximizing patient satisfaction.
Companies that help hospitals to meet and conform to the health care insurance industry's standards of reimbursable products and procedures have a bright future in the current global increase in people needing medical treatments.
That's why CareFusion (CFN) last week released quarterly earnings that were both strong and bodes well for the year ahead. CFN beat the Street's consensus estimate and added 1.6% to the company's gross operating margin.
Jim Cramer, the co-portfolio manager of Action Alerts PLUS and the host of CNBC's "Mad Money" recently interviewed the CEO of CFN and the video is well worth watching. You'll learn the company has a very active mergers and acquisitions pipeline and is in expansion mode.Here's an example of the kind of product CareFusion makes that hospital surgery rooms can hardly live without: On Tuesday the company launched a "take-apart laparoscopic scissor." This is in addition to its lineup of other precision, take-apart surgical instruments. The press release mentions that these kind of surgical instruments "... provide sterile, sharp blades and a new insulated shaft for each procedure. Designed for easy assembly and disassembly, the scissors feature an ergonomic, reusable ring-handle that also fits Snowden-Pencer take-apart clamps, dissectors and graspers. The handle is designed to more evenly distribute pressure than traditional handles and accommodates a variety of hand positions for comfort and precision during surgery. "To ensure the new scissors meet customer requirements, CareFusion conducted a limited market release to test the scissors in surgical procedures. After evaluation by more than 30 surgeons who performed approximately 60 procedures, the scissors received high levels of customer satisfaction and 100% of surgeons who evaluated the product indicated they would recommend it to peers." Jim Cramer and Stephanie Link actively manage a real money portfolio for his charitable trust -- enjoy advance notice of every trade, full access to the portfolio, and deep coverage of the latest economic events and market movements. Now here's where the rubber meets the road. If the surgeons and surgical assistants in an operating room will give tacit or direct approval of the efficacy of these products, sales are likely to soar. Apparently that's the kind of response CFN is receiving from professionals who have used its products.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV